QR kód

Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study

Abstract Background Despite recent advancements in migraine treatment, some patients continue to endure significant disease burden. Due to the controlled nature of randomized trials in migraine prevention, many real-world patients with comorbidities or prior exposure to certain therapies are exclude...

Celý popis

Uloženo v:
Hlavní autoři: Charles Argoff, Steven P. Herzog, Ryan M. Smith, Sameer V. Kotak, Liza Sopina, Yvonna Saltarska, Seema Soni-Brahmbhatt, Fawad A. Khan
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2024-04-01
Edice:The Journal of Headache and Pain
Témata:
Chronic migraine
Real-world
Eptinezumab
Preventive migraine treatment
Patient satisfaction
On-line přístup:https://doi.org/10.1186/s10194-024-01764-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky